Monogram Tech Gets FDA Clearance for Total Knee Arthroplasty System

Dow Jones
05/15
 

By Kelly Cloonan

 

Monogram Technologies has received clearance from the Food and Drug Administration for its mBôs Total Knee Arthroplasty system.

The company said Wednesday the clearance means it can start marketing the device, and is preparing for initial placements with surgeons in select areas of the U.S.

The placements aim to gather real-world clinical evidence and deepen surgeon engagement, the company said.

Monogram also gained regulatory approval from India's Central Drugs Standard Control Organization to import the system and initiate a 102-patient clinical investigation to evaluate its safety and effectiveness.

The company expects patient enrollment to begin shortly, with the first live surgeries in the next 90 business days.

The clearance and regulatory approval provide a clear path to commercial adoption in key markets, Chief Executive Ben Sexson said.

Shares rose 8.8% to $2.72 in after-hours trading Wednesday.

 

Write to Kelly Cloonan at kelly.cloonan@wsj.com

 

(END) Dow Jones Newswires

May 14, 2025 17:17 ET (21:17 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10